ALS drug funded by Ice Bucket Challenge finally wins FDA approval

Cambridge, Massachusetts based Amylyx Pharmaceuticals has received FDA approval for ALS aka Lou Gehrig's disease drug 'Relyvrio'. All Things Considered has an excellent article on the controversy surrounding FDA's recent Relyvrio approval:

Proponents of the drug say the small trial showed that it works. — Read the rest